Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. - Wikidata - awgldk - TriplyDB

Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy.

Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy.

http://www.wikidata.org/entity/Q40302175

about

Advances in the delivery of RNA therapeutics: from concept to clinical reality.mRNA Cancer Vaccines-Messages that Prevail.Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques.A new developing class of gene delivery: messenger RNA-based therapeutics.Rapid, Single-Cell Analysis and Discovery of Vectored mRNA Transfection In Vivo with a loxP-Flanked tdTomato Reporter Mouse.Improving Vaccine and Immunotherapy Design Using Biomaterials.Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy.mRNA vaccines - a new era in vaccinology.Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma.Kinetics of lipid-nanoparticle-mediated intracellular mRNA delivery and function.Multivalent ligand-receptor-mediated interaction of small filled vesicles with a cellular membrane.Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma.Preparation and Optimization of Lipid-Like Nanoparticles for mRNA Delivery.Tools for translation: non-viral materials for therapeutic mRNA delivery New opportunities for nanoparticles in cancer immunotherapy Transfection by cationic gemini lipids and surfactants Optimization of the Linker Length of Mannose-Cholesterol Conjugates for Enhanced mRNA Delivery to Dendritic Cells by Liposomes Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes

P2860

Q38706445-E8FDE78D-9EDF-4957-9150-B4D4CB767AA0 Q39236800-83D8F1E7-2CFB-4B1E-83A8-58355673FCC7 Q41993335-AB1838DC-2823-4EB1-9EE6-9624A975B225 Q45873514-EBA6F0C4-0ADF-451F-B273-B3609B0F6A55 Q47151105-578474D0-5D29-4C99-8920-6CCB87AB29DE Q47676665-EB20F294-1132-439A-A615-F4AE02B62479 Q47707153-B708F8B2-253E-4873-A989-FAC9D588E96B Q47736893-79D145CF-1D1F-4315-9065-29F6FC7AA4BA Q47962563-98B99D31-8DFB-4A9F-A009-1462C2399067 Q49715007-C3A6C929-D6A3-43EA-9522-9A5D3E2D6E7C Q49959209-45BBC514-9E23-4483-87E7-623F7612DF7C Q49960736-FD732C24-BCAB-4306-B936-6B2EFD684E9C Q50080885-75E793FB-3FA6-4A22-B20A-C4C460A903C8 Q52761615-CF0960C5-24B4-400A-86C2-3211472F377C Q56057560-3BA930DB-94A7-40F4-B4E1-DEB616908435 Q57069049-2706EDE8-227C-43D8-B070-2D8F414F95FD Q57139324-7C117D48-88E5-4824-8EBC-4269C6AB1FEC Q58762847-C13FF274-F839-41FC-A052-C8705B2BE1E3 Q59133785-A5006A74-B0EE-4584-8C67-B5DE7B5E8712

P2860

Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy.

http://www.wikidata.org/entity/Q40302175

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy.

@en

type

label

Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy.

@en

prefLabel

Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy.

@en

P1433

Q40302175-7D50910D-DEEC-4533-860D-60B4B34000B2

P1476

Q40302175-71DC28E2-1038-49BA-898A-F3F0EDCBD157

P2093

Q40302175-77C4F469-C1B3-4592-91BA-5F6E6136A52C

Q40302175-807CBBB9-56CD-45F0-8E27-17AF3C027F9D

Q40302175-A3B13FE6-DC21-4C1E-891F-50005F9DA4F3

Q40302175-A638CA07-3E5F-4B49-A0AE-D1B4AB32F8A9

Q40302175-CBFE0DC1-6222-4473-978F-3957AFCF1B4B

P2860

Q40302175-0CFF5E01-985E-4E15-B045-D85B70815CE9

Q40302175-0F4A7D65-AB00-4839-A73B-0312736473D3

Q40302175-1197ECCA-49B5-46E4-954A-CF46ADB4631F

Q40302175-1E3112C4-4476-480A-ACEF-F32A79DD4D1C

Q40302175-1E8F3D01-7A6D-4EAA-89F8-AD22EAE80AE7

Q40302175-2EAD32AF-253B-4ECE-87D1-4518B77D8D36

Q40302175-2EB79222-D2E0-4F03-A31F-BA9A99756BA0

Q40302175-2F9821AC-3155-43D2-B32C-6CACA0306EE7

Q40302175-371BB06F-F539-429D-B15F-0FDF7C88D43D

Q40302175-38CDFB44-2E1B-42A7-992E-46673B2CBC1E

P304

Q40302175-FC2A0E95-C6E8-47E2-9B99-203C8EDEB6D7

P31

Q40302175-4E2EC754-0D75-4ABB-BCA7-D24D6A53977F

P356

Q40302175-9423A5B2-8933-40DF-98F9-61983344C1AE

P407

Q40302175-C10E9679-7FF7-40AB-A616-D83239E3B43E

P433

Q40302175-36F08BA9-7ECF-49E5-BB29-8E2198A603AB

P478

Q40302175-D662F278-100C-418C-856B-28742054273A

P50

Q40302175-04D31511-C83C-487F-914A-4C46B4991C16

Q40302175-39E259D7-08A0-42EB-8EED-23F9BBCF1B87

Q40302175-4BCFA0E3-0B74-4EB5-B35F-BA4DAB3D8555

Q40302175-BCD509E3-979A-4628-A896-5EC9833ED511

P577

Q40302175-A965EA80-11DC-405C-996C-82FF06C80A53

P698

Q40302175-13FACD87-75AB-4F2C-9DDB-5FDEBC4E88EE

P921

Q40302175-513CE72A-AE11-44C6-B411-AF2D3A778EB3

Q40302175-F0D00AF2-6C7D-40A1-B95C-1E05EAD4AF94

P932

Q40302175-C74858E5-5F06-4C9B-8984-670A7BD18623

P356

ACS.NANOLETT.6B03329

P1433

P1476

Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy.

@en

P2093

Andreas M Reichmuth

http://www.w3.org/2001/XMLSchema#string

Daniel Blankschtein

http://www.w3.org/2001/XMLSchema#string

Daniel G Anderson

http://www.w3.org/2001/XMLSchema#string

J Robert Dorkin

http://www.w3.org/2001/XMLSchema#string

Owen S Fenton

http://www.w3.org/2001/XMLSchema#string

P2860

Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA

Lipopolysaccharide endotoxins

Cancer vaccines

Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

The three Es of cancer immunoediting

Innate immune pattern recognition: a cell biological perspective

The future of immune checkpoint therapy

The mannose receptor

A robust and high-throughput Cre reporting and characterization system for the whole mouse brain

P304

1326-1335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACS.NANOLETT.6B03329

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Michael J. Mitchell

Robert Samuel Langer, Jr.

Matthias A Oberli

P577

2016-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28273716

http://www.w3.org/2001/XMLSchema#string

P921

P932

5523404

http://www.w3.org/2001/XMLSchema#string